Should Shares CRISPR Therapeutics Be a February Pick?
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Compare SP 500 and Total Market funds for retirement planning. Learn key differences, risks, and how to align with your long-term goals.
28,602 articlesBiotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Russia is moving to block foreign crypto exchanges unless they comply with new domestic regulations, aiming to funnel...
Nvidia’s latest earnings release produced solid numbers, but traders say the real move will come from the March GTC. ...
Hut 8 and Riot Platforms jump as Bitcoin miners pivot to AI infrastructure, signaling a new revenue model powered by ...
TON climbs from about $1.30 to $2.50 in three days as Telegram signals a major governance shift, slashing fees and ta...
Bitcoin found itself at a fresh test of a long standing benchmark after slipping below a key line used by traders to ...
Dogecoin's network activity surged to a multi-month high, fueling talk of a potential breakout. Analysts weigh how on...
The housing market just split into two distinct paths: rising prices in the Northeast and cooler markets on the West ...
DTCC's decision to anchor tokenized securities on Stellar shifts the cross-border payments landscape. Ripple's ODL sh...
July 2026 brings a fresh wave of opportunities in semiconductors. This guide reveals five names with durable demand, ...
Susquehanna lifts Baidu's price target to $140 while maintaining a Neutral rating, citing AI Cloud strength but ongoi...
Uncover five key quotes from AMD's earnings call and what they could mean for the stock in 2026. Learn how to transla...